Araújo AM, Valente MJ, Carvalho M, Dias da Silva D, Gaspar H, Carvalho F, de Lourdes Bastos M, Guedes de Pinho P (2014) Raising awareness of new psychoactive substances: chemical analysis and in vitro toxicity screening of ‘legal high’ packages containing synthetic cathinones. Arch Toxicol

Bonano JS, Glennon RA, De Felice LJ, Banks ML, Negus SS (2014) Abuse-related and abuse-limiting effects of methcathinone and the synthetic “bath salts” cathinone analogs methylenedioxypyrovalerone (MDPV), methylone and mephedrone on intracranial self-stimulation in rats. Psychopharmacology (Berlin) 231:199–207

Article  CAS  Google Scholar 

Bondareva TS, Young R, Glennon RA (2002) Central stimulants as discriminative stimuli. Asymmetric generalization between (−)ephedrine and S(+)methamphetamine. Pharmacol Biochem Behav 74:157–162

Article  CAS  PubMed  Google Scholar 

Calkins RF, Aktan GB, Hussain KL (1995) Methcathinone: the next illicit stimulant epidemic? J Psychoactive Drugs 27:277–285

Article  CAS  PubMed  Google Scholar 

Carroll FI, Blough BE, Abraham P, Mills AC, Holleman JA, Wolckenhauer SA, Decker AM, Landavazo A, McElroy KT, Navarro HA, Gatch MB, Forster MJ (2009) Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction. J Med Chem 52:6768–6781

Cozzi NV, Brandt SD, Daley PF, Partilla JS, Rothman RB, Tulzer A, Sitte HH, Baumann MH (2013) Pharmacological examination of trifluoromethyl ring-substituted methcathinone analogs. Eur J Pharmacol 699:180–187

Article  PubMed Central  CAS  PubMed  Google Scholar 

Dal Cason TA, Young R, Glennon RA (1997) Cathinone: an investigation of several N-alkyl and methylenedioxy analogs. Pharmacol Biochem Behav 58:1109–1116

Article  CAS  PubMed  Google Scholar 

Drug Enforcement Administration DJ (2014) Schedules of controlled substances: temporary placement of 10 synthetic cathinones into Schedule I. Final order. Fed Regist 79:12938–12943

Google Scholar 

Elliott S, Evans J (2014) A 3-year review of new psychoactive substances in casework. Forensic Sci Int 243C:55–60

Article  Google Scholar 

Emerson TS, Cisek JE (1993) Methcathinone: a Russian designer amphetamine infiltrates the rural midwest. Ann Emerg Med 22:1897–1903

Article  CAS  PubMed  Google Scholar 

Eshleman AJ, Wolfrum KM, Hatfield MG, Johnson RA, Murphy KV, Janowsky A (2013) Substituted methcathinones differ in transporter and receptor interactions. Biochem Pharmacol

Fantegrossi WE, Gannon BM, Zimmerman SM, Rice KC (2013) In vivo effects of abused ‘bath salt’ constituent 3,4-methylenedioxypyrovalerone (MDPV) in mice: drug discrimination, thermoregulation, and locomotor activity. Neuropsychopharmacol 38:563–573

Article  CAS  Google Scholar 

Gatch MB, Forster MJ, Janowsky A, Eshleman AJ (2011) Abuse liability profile of three substituted tryptamines. J Pharmacol Exp Ther 338:280–289

Article  PubMed Central  CAS  PubMed  Google Scholar 

Gatch MB, Taylor CM, Forster MJ (2013) Locomotor stimulant and discriminative stimulus effects of ‘bath salt’ cathinones. Behav Pharmacol 24:437–447

Article  PubMed Central  CAS  PubMed  Google Scholar 

Gil D, Adamowicz P, Skulska A, Tokarczyk B, Stanaszek R (2013) Analysis of 4-MEC in biological and non-biological material—three case reports. Forensic Sci Int 228:e11–e15

Article  CAS  PubMed  Google Scholar 

Glennon RA (2014) Bath salts, mephedrone, and methylenedioxypyrovalerone as emerging illicit drugs that will need targeted therapeutic intervention. Adv Pharmacol 69:581–620

Article  CAS  PubMed  Google Scholar 

Glennon RA, Yousif M, Naiman N, Kalix P (1987) Methcathinone: a new and potent amphetamine-like agent. Pharmacol Biochem Behav 26:547–551

Article  CAS  PubMed  Google Scholar 

Kaminski BJ, Griffiths RR (1994) Intravenous self-injection of methcathinone in the baboon. Pharmacol Biochem Behav 47:981–983

Article  CAS  PubMed  Google Scholar 

Katz JL, Agoston GE, Alling KL, Kline RH, Forster MJ, Woolverton WL, Kopajtic TA, Newman AH (2001) Dopamine transporter binding without cocaine-like behavioral effects: synthesis and evaluation of benztropine analogs alone and in combination with cocaine in rodents. Psychopharmacology (Berl) 154:362–374

Kohut SJ, Fivel PA, Blough BE, Rothman RB, Mello NK (2013) Effects of methcathinone and 3-Cl-methcathinone (PAL-434) in cocaine discrimination or self-administration in rhesus monkeys. Int J Neuropsychopharmacol 16:1985–1998

Article  CAS  PubMed  Google Scholar 

Li SM, Campbell BL, Katz JL (2006) Interactions of cocaine with dopamine uptake inhibitors or dopamine releasers in rats discriminating cocaine. J Pharmacol Exp Ther 317:1088–1096

Article  CAS  PubMed  Google Scholar 

López-Arnau R, Martínez-Clemente J, Pubill D, Escubedo E, Camarasa J (2012) Comparative neuropharmacology of three psychostimulant cathinone derivatives: butylone, mephedrone and methylone. Br J Pharmacol 167:407–420

Article  PubMed Central  PubMed  Google Scholar 

Marinetti LJ, Antonides HM (2013) Analysis of synthetic cathinones commonly found in bath salts in human performance and postmortem toxicology: method development, drug distribution and interpretation of results. J Anal Toxicol 37:135–146

Article  CAS  PubMed  Google Scholar 

Marusich JA, Grant KR, Blough BE, Wiley JL (2012) Effects of synthetic cathinones contained in “bath salts” on motor behavior and a functional observational battery in mice. Neurotoxicology 33:1305–1313

Article  PubMed Central  CAS  PubMed  Google Scholar 

Meyer MR, Vollmar C, Schwaninger AE, Wolf E, Maurer HH (2012) New cathinone-derived designer drugs 3-bromomethcathinone and 3-fluoromethcathinone: studies on their metabolism in rat urine and human liver microsomes using GC-MS and LC-high-resolution MS and their detectability in urine. J Mass Spectrom 47:253–262

Article  CAS  PubMed  Google Scholar 

National Research Council (2011) Guide for the care and Use of laboratory animals, 8th edn. The National Academies Press, Washington, D.C

Google Scholar 

Schechter MD (1997a) Discriminative characteristics of high and low cocaine administration: effect of other psychostimulants. Pharmacol Biochem Behav 56:457–463

Article  CAS  PubMed  Google Scholar 

Schechter MD (1997b) Drug-drug discrimination: stimulus properties of drugs of abuse upon a serotonergic-dopaminergic continuum. Pharmacol Biochem Behav 56:89–96

Article  CAS  PubMed  Google Scholar 

Simmler LD, Rickli A, Hoener MC, Liechti ME (2014) Monoamine transporter and receptor interaction profiles of a new series of designer cathinones. Neuropharmacology 79:152–160

Article  CAS  PubMed  Google Scholar 

UNODC (2013) The challenge of new psychoactive substances. United Nations Office on Drugs and Crime, Vienna, Austria, pp 20131–108

Uralets V, Rana S, Morgan S, Ross W (2014) Testing for designer stimulants: metabolic profiles of 16 synthetic cathinones excreted free in human urine. J Anal Toxicol 38:233–241

Article  CAS  PubMed  Google Scholar 

van der Schoot JB, Ariens EJ, van Rossum JM, Hurkmans JATM (1962) Phenylisopropylamine derivatives, structure and action. Arznemittel-Forschung 12:902–907

Google Scholar 

Varner KJ, Daigle K, Weed PF, Lewis PB, Mahne SE, Sankaranarayanan A, Winsauer PJ (2012) Comparison of the behavioral and cardiovascular effects of mephedrone with other drugs of abuse in rats. Psychopharmacology (Berlin) 225:675–685

Article  Google Scholar 

Young R, Glennon RA (1998) Discriminative stimulus effects of S(−)-methcathinone (CAT): a potent stimulant drug of abuse. Psychopharmacology (Berl) 140:250–256

Article  CAS  Google Scholar